Regulus Therapeutics (RGLS) - NASDAQ
  • StockConsultant | Send Message 15 Jun

    Stocks at support with high trade quality $FB $EBS $GPRE $HUBS $NTES $PETX $PCLN $RARE $RGLS $SINA $VRTX analysis http://chart.st
    Reply
      • Bret Jensen | Send Message 1 Apr

        Biotech Forum Daily Digest: Medivation Roller-Coaster, Spotlight On Regulus Therapeutics $RGLS http://seekingalpha.com/a/2cxhs
        Reply
          • StockConsultant | Send Message 15 Mar

            Bio stocks w/ high trade quality: $BLUE $CLVS $AMAG $CRIS $PBYI $RGLS $RVNS http://bit.ly/1PPfyy3
            Reply
              • StockConsultant | Send Message 14 Mar

                Stocks at support w/ high trade quality: $DDD $CFMS $EIGI $RGLS $SMCI $TMST http://bit.ly/1piWmCb
                Reply
                  • EP Vantage | Send Message 19 Feb

                    Regulus Add-On Could Help Regulate Hep C Drug Costs $RGLS http://seekingalpha.com/a/2bt68
                    Reply
                      • freefdawatchlist | Send Message 18 Feb

                        http://bit.ly/1QKDwue After Hour Earnings: $RGLS, $CENX, $JWN, $IRWD, $AHS, $LHO
                        Reply
                          • Jonathan Weber | Send Message 18 Feb

                            Should Gilead Investors Fear Regulus? $GILD, $RGLS http://seekingalpha.com/a/2bpy4
                            Reply
                              • freefdawatchlist | Send Message 18 Feb

                                http://bit.ly/1QKDwue Earning Play for Feb 18th: $MPEL, $WAB, $VA, $EIGI, $CAB, $DNR, $AGIO, $RGLS, $CENX, $JWN, $IRWD
                                Reply
                                  • silver_hawk4 | Send Message 17 Feb

                                    $RGLS PreMarket
                                    Reply
                                      • wilkinson99 | Send Message 17 Feb

                                        Premarket Top % Gainers: $ATOS $RGLS $FLXN $PPHM $SHOP $PCLN $FOSL Top % Losers: $CPRX $MPEL $RAX $CERN $DWTI $UVXY
                                        Reply
                                          Company Description
                                          Regulus Therapeutics, Inc. engages in the discovery and development of drugs target microRNAs to treat a broad range of diseases. It is developing RG-101, which targets miR-122, a host factor for the hepatitis C virus infection. The company was founded in September 2007 and is headquartered in... More
                                          Sector: Healthcare
                                          Industry: Drug Related Products
                                          Country: United States